Release Notes for 2026-03-30: Number of new affinity data: 11671 Number of compounds (ligands) new to BindingDB: 6142 Number of Targets new to BindingDB: 8 New Targets: GTPase KRas [G12A] (P01116[G12A]): 6 inhibitors GTPase KRas [G12R] (P01116[G12R]): 6 inhibitors Interferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116] (unmapped): 171 inhibitors Major DNA-binding protein (P04296): 213 inhibitors Serine/threonine protein kinase UL97 (P16788): 479 inhibitors Serine/threonine-protein kinase ULK1/Autophagy-related protein 13 (unmapped): 39 inhibitors Zinc finger and BTB domain-containing protein 7A (O95365): 54 inhibitors Number of new Entries: 57 PubMed id or Patent id Title US11116760 Quinoline derivatives US12465588 Indole carboxamide derivative and pharmaceutical composition containing same US12466803 BCKDK inhibitors and/or degraders US12466809 CDK2/5 degraders and uses thereof US12466818 Thienyl-aniline compounds for treatment of dermal disorders US12466821 Antiviral pyridopyrazinedione compounds US12466840 Small molecule inhibitors of KRAS proteins US12466841 Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonists US12472179 Combination of a CBP/p300 bromodomain inhibitor and a KRAS inhibitor for the treatment of cancer US12473262 Aryl hydrocarbon receptor activators US12473263 Bicyclic inhibitors of CBX chromodomains US12473278 Imidazole derivative expressing FLT3 inhibitory activity, and use thereof US12473282 Biphenyl fluorine double bond derivative, preparation method therefor, and pharmaceutical application thereof US12473284 Small molecule inhibitors of ULK1 US12473289 Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use US12473295 Substituted straight chain spiro derivatives US12473296 Perk inhibiting compounds US12473298 Amide compounds, preparation method therefor, and use thereof in the medical field US12473301 Isoquinoline compounds for the treatment of cancer US12473303 4-[[(7-aminopyrazolo[1,5-a]pyrimidin-5-yl)amino methyl]piperidin-3-ol compounds and their therapeutic use US12473304 Heterocyclic PAD4 inhibitors US20240208937 Compounds and Their Use for Treatment of Hemoglobinopathies US20250345339 DOSES AND REGIMENS OF HER2 INHIBITORS US20250346564 INHIBITORS OF PARG US20250346571 BICYCLIC DERIVATIVE PARP INHIBITOR AND USE THEREOF US20250346572 NON-ACID INHIBITORS OF INOSITOL HEXAKISPHOSPHATE KINASE (IP6K) AND METHODS OF USE THEREOF US20250346573 AZAQUINOLINONE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF US20250346584 NOVEL KAPPA OPIOID LIGANDS US20250346585 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS US20250346587 NITROGEN-CONTAINING FIVE-MEMBERED HETEROCYCLIC DERIVATIVES AS CHECKPOINT KINASE 1 INHIBITOR AND USES THEREOF US20250346592 HETEROCYCLIC PAD4 INHIBITORS US20250346593 IMIDAZO(1,2-1)PYRIDINE DERIVATIVES AS RIPK2 INHIBITORS US20250346597 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES US20250346599 TRICYCLIC PHTHALAZINONE PARP INHIBITORS AND METHODS OF USE US20250346600 TRICYCLIC DERIVATIVES AND RELATED USES US20250346604 TRIAZOLOPYRIDAZINE COMPOUNDS USEFUL AS RAC1 INHIBITORS US20250346616 ROCK INHIBITORS AND USES THEREOF US20250346922 COMPOUNDS FOR IMPROVEMENT OF VIRAL PRODUCTION US20250352541 THERAPEUTIC FOR CANCER REFRACTORY TO IMMUNE CHECKPOINT INHIBITOR US20250352542 TRPV2 CHANNEL BLOCKERS AND USE THEREOF US20250352549 SUBSTITUTED HETEROCYCLIC COMPOUND DERIVATIVES AND THEIR PHARMACEUTICAL USE US20250353816 QUINOLINES AS MODULATORS OF POLRMT US20250353819 ARYL HYDANTOIN COMPOUNDS AND METHODS OF USE US20250353820 ANTIVIRAL PYRAZOLOPYRIDINONE COMPOUNDS US20250353833 DPP9 BINDING COMPOUNDS US20250353842 BICYCLIC AMINE CDK12 INHIBITORS US20250353852 COMPOUNDS AND COMPOSITIONS THAT INHIBIT PIKFYVE US20250353853 FLAVIVIRUS INHIBITORS US20250353856 COMPOUND ACTIVE AS INHIBITOR OF COLONY STIMULATION FACTOR-1 RECEPTOR (CSF-1R) US20250353857 COMPOUND ACTIVE AS INHIBITOR OF COLONY STIMULATION FACTOR-1 RECEPTOR (CSF-1 R) US20250353858 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES US20250353863 TRICYCLIC SPIROLACTAM COMPOUNDS WITH ANTIMYCOBACTERIAL ACTIVITY US20250353864 INDAZOLE CONTAINING MACROCYCLES AND THEIR USE US20250353874 GLUCOCORTICOID RECEPTOR AGONISTS WO2024083933 2,4,6-TRISUBSTITUTED 1,3,5-TRIAZINES AS MODULATORS OF CX3CR1 WO2024186584 ALPHA-SYNUCLEIN BINDERS AND METHODS OF USE WO2024233846 INHIBITORS AND DEGRADERS OF PIP4K PROTEIN